US Markets for Cardiac Surgery 2007

Abstract

Valued at nearly $1.4 billion in 2006, the US market for cardiac surgery devices will continue to be supported by the increasing incidence of heart disease and the expected launch of novel approaches to cardiac surgery.

While instruments for more traditional cardiac surgery, including heart valve and coronary artery bypass graft (CABG) devices, contributed the largest shares of revenues to the overall market in 2006, future market growth will be driven by increasing adoption of new and less invasive cardiac surgery technologies. These devices promise to expand the potentially treatable patient population.